Search Results

Multiply Labs and Akron Bio (“Akron”), a leading supplier of critical materials and services for advanced therapies, today announced a non-exclusive partnership focused on automating and standardizing the use of cytokines in cell therapy manufacturing.

Akron Bio today announced the appointment of Christopher Murphy as Chief Executive Officer.

Akron Bio (“Akron”), a leading supplier of critical inputs for cell and gene therapies, today announced that Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) has granted Akron Eligibility Confirmation for its cGMP Virus Inactivated Human Fibronectin.

Future Pak—whose acquisition offer was rejected by Vanda Pharmaceuticals last summer—is offering to buy Theratechnologies for an unsolicited $255 million. The Canadian biotech is under an exclusivity agreement with another yet-to-be-disclosed potential purchaser.

Bo Wang is a renowned AI scientist at the University of Toronto. He’s bringing his open-source culture and computational biology to Xaira Therapeutics in June.

Akron Children’s Hospital has been awarded a three-year $1.3 million grant from the National Institutes of Health /National Institute of Nursing Research to better define the practices of high-quality pediatric palliative care, particularly in seeking out the voices of the children, teens and young adults at the center of that care.